Cerity Partners LLC Acquires 2,894 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Cerity Partners LLC increased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 12.3% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 26,339 shares of the company’s stock after buying an additional 2,894 shares during the quarter. Cerity Partners LLC’s holdings in Henry Schein were worth $1,920,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Cromwell Holdings LLC lifted its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC purchased a new stake in Henry Schein during the second quarter valued at $31,000. Blue Trust Inc. increased its position in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares during the period. Finally, Mather Group LLC. boosted its position in Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after purchasing an additional 216 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $76.50 on Tuesday. The stock has a 50-day moving average price of $71.57 and a 200 day moving average price of $69.88. The stock has a market capitalization of $9.54 billion, a P/E ratio of 31.48, a P/E/G ratio of 2.21 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the firm posted $1.32 EPS. The company’s revenue was up .4% on a year-over-year basis. Equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on HSIC shares. JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Robert W. Baird cut their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $79.38.

Insider Buying and Selling at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.